Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Cropper (James) (CRPR) by Steve Moore in ShareProphets
- Buy Close Brothers Group (CBG) by Shore Capital
- Buy WH Smith (SMWH) by Canaccord Genuity
- Hold Halma (HLMA) by Shore Capital
- Buy Speedy Hire (SDY) by Canaccord Genuity
- Buy Norcros (NXR) by Shore Capital
- Buy XPS Pensions Group (XPS) by Canaccord Genuity
- Hold CMC Markets (CMCX) by Shore Capital
- Hold Warehouse Reit (WHR) by Shore Capital
- Buy Jet2 (JET2) by Canaccord Genuity
- Underperform Halma (HLMA) by Jefferies
- Avoid Churchill China (CHH) by Steve Moore in ShareProphets
- Buy Sage Group (SGE) by Bank of America
- Hold JD Sports Fashion (JD.) by Harvey Jones in The Motley Fool
- Hold Liontrust Asset Management (LIO) by Berenberg
- Overweight Oxford Nanopore Technologies (ONT) by Barclays
- Underweight Sage Group (SGE) by Barclays
- Overweight Spire Healthcare Group (SPI) by Barclays
- Overweight Convatec Group (CTEC) by Barclays
- Equal Weight Crest Nicholson Holdings (CRST) by Barclays
Aptamer Group (APTA) Share Price
Health Care Sector
NOTE: This is based on 17 open tips for Aptamer Group (APTA)
| Latest Bid : 0.27p | Latest Ask : 0.32p |
| High Today : 0.32p | Low Today : 0.27p |
| This Years High : 1.32p | This Years Low : 0.20p |
| Volume : 28,298,569 | MKT Cap : £5.76M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Aptamer Group (APTA) Overview
Aptamer Group operates within the life sciences sector and is a leader in the provision of aptamer discovery and selection services and in developing aptamer-based reagents. The Company operates across three life science sectors: custom services (research and bioprocessing tools), diagnostics and therapeutics. The Company strives to deliver transformational solutions that meet the needs of developers and users of diagnostic platforms, scientific researchers and companies involved in drug development and manufacturing.Aptamer Group (APTA) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2024-11-06 17:35:00 06/11/2024 | -22.92% |
| Avoid | Steve Moore | Premium Only | 2024-06-14 10:55:00 14/06/2024 | 57.86% |
| Avoid | Steve Moore | Premium Only | 2024-05-23 13:20:00 23/05/2024 | 60.67% |
| Avoid | Steve Moore | Premium Only | 2024-02-05 11:10:00 05/02/2024 | 60.67% |
| Avoid | Steve Moore | Premium Only | 2023-12-14 14:30:00 14/12/2023 | 75.42% |
Aptamer Group (APTA) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.27p | Latest Ask : 0.32p |
| High Today : 0.32p | Low Today : 0.27p |
| This Years High : 1.32p | This Years Low : 0.20p |
| Volume : 28,298,569 | MKT Cap : £5.76M |
Aptamer Group Overview
Aptamer Group operates within the life sciences sector and is a leader in the provision of aptamer discovery and selection services and in developing aptamer-based reagents. The Company operates across three life science sectors: custom services (research and bioprocessing tools), diagnostics and therapeutics. The Company strives to deliver transformational solutions that meet the needs of developers and users of diagnostic platforms, scientific researchers and companies involved in drug development and manufacturing.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Aptamer Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2024-11-06 17:35:00 06/11/2024 | -22.92% |
| Avoid | Steve Moore | Premium Only | 2024-06-14 10:55:00 14/06/2024 | 57.86% |
| Avoid | Steve Moore | Premium Only | 2024-05-23 13:20:00 23/05/2024 | 60.67% |
| Avoid | Steve Moore | Premium Only | 2024-02-05 11:10:00 05/02/2024 | 60.67% |
| Avoid | Steve Moore | Premium Only | 2023-12-14 14:30:00 14/12/2023 | 75.42% |